Delivery Order SPE2DB22D1017-SPE2DB24FF2AP
Award Date
1/29/24
Potential Completion Date
1/30/24
Potential Value
$15K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract worth $18,105.84 by the Defense Logistics Agency (DLA) to provide ELIQUIS 5 MG TABLET 60S. The contract has a completion date of February 7, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $7,436.59 firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical to provide ELIQUIS 5 MG TABLET 60S. The delivery order has a completion date of February 22, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 and running through December 31, 2025, which serves as the primary...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price Delivery Order contract by the Defense Logistics Agency (DLA) to provide ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, with a potential value of $4,459.82. The contract has a completion date of February 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is not associated with any set-aside designations. This award is part of a larger Indefinite...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $32,854.44 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide ELIQUIS 5 MG TABLET 60S. The contract has a completion date of February 28, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 and a performance period through December 31, 2025....
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a Firm Fixed Price Delivery Order contract worth $37,040.91 by the Defense Logistics Agency (DLA) to provide ELIQUIS 5 MG TABLET 60S. The contract has a completion date of February 6, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is not associated with any set-aside program. Additionally, Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $39,230.84 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, with a completion date of May 11, 2022. This delivery order is issued under Amerisourcebergen Drug Corp's single award indefinite delivery contract (IDC) with DLA, which has a potential value of $999,999,999.00 and a performance...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $11,110.43 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to supply ELIQUIS 5 MG TABLET 60S. The contract is set to be completed by February 13, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide pharmaceutical...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The contract, valued at $14,485.71, has a completion date of January 31, 2024. This award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued up to $999,999,999.00 and in effect...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, with a potential value of $11,482.96 and a completion date of March 7, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and...
Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, was awarded a firm-fixed-price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide ELIQUIS 2.5 MG TABLET 60S, a pharmaceutical product, with a potential value of $4,698.39. The contract has a completion date of February 2, 2024. Amerisourcebergen Drug Corp is the prime contractor and sole awardee for this delivery order, which is...